You searched for "Meniere’s disease"

12 results found

Reviewing Meniere’s disease

This was a sizeable literature review (93 references) of not only the office-based treatments for Meniere’s disease but also the various aetiological theories regarding it. They also highlight the amended International Criteria for Meniere’s disease diagnosis (2015), comparing it against...

Thyroid dysfunction and Meniere’s disease: is there a relationship?

The set of symptoms described as Meniere’s disease may have several causative factors. Timothy Hain and Patthida Maroongroge look for a relationship in the literature between Meniere’s disease and hypothyroidism. Meniere’s disease (MD) affects around two in 1000 people and...

Composing with Meniere’s disease: a personal reflection

Is a fluctuating hearing loss and composing music incompatible? Professor Andrew Hugill discusses his personal experience of Meniere’s disease and the work that has developed as a result of the condition. As I write this article, I am in the...

Canal plugging for intractable Meniere’s disease

In this single centre retrospective study, the authors applied semicircular canal plugging, well known as a treatment for refractory BPPV, to intractable unilateral Meniere’s disease (MD) that had failed to respond to medical treatment with betahistine and hydrochlorothiazide. However, in...

Association between Meniere’s disease and vestibular migraine

Meniere’s disease (MD) and vestibular migraine (VM) are two conditions with overlap in their symptoms. There is often a lack of understanding regarding symptom-based differentiation between them. MD presents with episodic vertigo, fluctuating hearing loss and tinnitus. MD has been...

MRI in diagnosis Meniere’s disease: what is the evidence?

The utility of magnetic resonance imaging (MRI) in the diagnosis of Meniere’s disease (MD) has attracted a lot of interest recently. It is well accepted that the saccule is the most common vestibular organ affected by endolymphatic hydrops (EH) and...

The role of cVEMPs in the diagnosis of Meniere’s disease

This study sets out to determine the most useful metrics to use from cervical-vestibular evoked myogenic potential (c-VEMP) tests when the diagnosis of Meniere’s disease (MD) is unclear, or as a follow-up tool. It is known that cVEMPs can detect...

Clinical features of BPPV in Meniere’s disease

It is an observation that BPPV appears to be commonly associated with Meniere’s disease (MD). This five-year study compared features and treatment outcomes between patients presenting with MD in conjunction with unilateral BPPV and a group of BPPV patients without...

Review of surgical treatments of intractable Meniere’s disease

This is a nice summary of the evidence available for the surgical treatments for intractable Meniere’s disease. To summarise, in five-10 years, over 90% of vestibular neurectomy cases, more than 80% of intratympanic gentamycin treatment, and 70-80% of endolymphatic sac...

Triple semicircular canal occlusion and Meniere’s disease: a rising alternative treatment?

Patients with dizziness form a large part of the workload for ENT surgeons. In the overwhelming majority of cases, management will be medical and successful. However, occasionally some patients present a challenge when they have not responded to conventional treatments....

High dose betahistine as effective as, but slower acting compared to intratympanic dexamethasone in intractable Meniere’s disease

The management of intractable Meniere’s disease poses a complex conundrum to otolaryngologists. The focus of treatment is decreasing the severity and frequency of vertigo and tinnitus whilst trying to preserve hearing. Betahistine has been used for many years in the...

Patients with auto-immune Meniere’s disease more likely to respond to intratympanic steroids

The authors retrospectively reviewed the duration of symptom control after intratympanic dexamethasone (IT) injections in 27 patients with Meniere’s disease (MD) over a six-year period. The patients received two IT injections of 3.3mg/ml of dexamethasone one-to-two weeks apart. Eleven patients...